ELVERA
LIVE

Serial Number

79227985

Owner

Swedish Orphan Biovitrum AB (publ)

Attorney

Donna J. Bunton

Filing Date

Dec 21, 2017

Add to watchlist:

No watchlists yet
View on USPTO

ELVERA Trademark

Serial Number: 79227985 • Registration: 5736037

ELVERA is a trademark filed by Swedish Orphan Biovitrum AB (publ) on December 21, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Swedish Orphan Biovitrum AB (publ) (33 trademarks)

SE-112 76 Stockholm

Entity Type: 99

Trademark Details

Filing Date

December 21, 2017

Registration Date

April 30, 2019

Published for Opposition

February 12, 2019

Cancellation Date

November 14, 2025

Goods & Services

Research and development of pharmaceuticals, protein pharmaceuticals, biological pharmaceuticals, proteins, protein structures, chemical modification of substances, compounds for efficient effect of drugs, compounds for controlled release of pharmaceutical substances within the pharmaceutical field; none of the aforementioned being cosmetic research

Medical and pharmaceutical preparations in the field of human medicine for the prevention and treatment of diseases and conditions in the therapeutic areas of hematology, inflammation, genetics and metabolism; medical drugs for human use for the treatment of diseases and conditions in the therapeutic areas of hematology, inflammation, genetics and metabolism; dietetic and nutritional preparations and substances in the form of foods and beverages adapted for medical use; protein pharmaceuticals in the field of human medicine for the prevention and treatment of diseases and conditions in the therapeutic areas of hematology, inflammation, genetics and metabolism; modified chemical compounds for medical purposes, namely, for the treatment of diseases and conditions in the therapeutic areas of hematology, inflammation, genetics and metabolism; modified protein arrays for medical use in the therapeutic areas of hematology, inflammation, genetics and metabolism; none of the aforementioned goods being cosmetic skin care preparations and cosmetics

Filing History

CANCELLED SECTION 71
Nov 14, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 30, 2024 REM3
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Mar 16, 2021 LIMN
LIMITATION OF GOODS RECEIVED FROM IB
Nov 20, 2020 LIMG
NEW REPRESENTATIVE AT IB RECEIVED
Dec 20, 2019 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 6, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 16, 2019 FICS
FINAL DISPOSITION PROCESSED
Aug 15, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 30, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 30, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 12, 2019 NPUB
PUBLISHED FOR OPPOSITION
Feb 12, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Feb 8, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 23, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 23, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 23, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 4, 2019 CNSA
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Jan 3, 2019 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Dec 28, 2018 LIMG
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 10, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 9, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 9, 2018 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 1, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 1, 2018 REAP
REFUSAL PROCESSED BY IB
Apr 27, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 9, 2018 RFCS
REFUSAL PROCESSED BY MPU
Apr 9, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 3, 2018 RFCR
NON-FINAL ACTION WRITTEN
Apr 2, 2018 CNRT
ASSIGNED TO EXAMINER
Apr 2, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 10, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 6, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 1, 2018 REPR